Multilocus sequence typing (MLST) extended with flaB typing of 425 Campylobacter jejuni isolates and 42
Campylobacter coli isolates revealed quite a low overlap between human isolates from travel-associated and domestic cases in Switzerland. Men were more frequently affected by Campylobacter than women, but strains from women and, overall, from travel-associated cases showed mutations conferring quinolone resistance more frequently than strains from men and domestic cases, respectively.
C
ampylobacter jejuni and Campylobacter coli are the major causes of bacterial gastroenteritis worldwide. In Switzerland, the reported incidence is one of the highest in Europe (3, 4, 9, 21, 23) . The infection occurs mainly after the handling of raw meat and the consumption of undercooked contaminated meat, but traveling abroad has also been recognized as a risk factor (9, (20) (21) (22) . To gain information on genotypes and antibiotic resistances of strains implicated in either domestic or travel-associated cases, 425 C. jejuni isolates and 42 C. coli isolates representing 8.2% of all reported cases in the sampling period from June to December 2009 in Switzerland were investigated ( Table 1) . Most of the isolates (383; 82.0%) were obtained from domestic cases. Taking into consideration the incubation time of Campylobacter spp. and how long clinical symptoms last, the remaining 84 isolates (18.0%) from patients who had been abroad within the last 2 weeks prior to medical consultation were classified as travel associated (4) . This is quite a low rate in comparison to that of an earlier case-control study conducted in Switzerland, where 46.1% of investigated cases were associated with foreign travel (22) . The distribution of isolates within the particular age groups of patients was highly reflected in the proportion calculated for all reported cases in Switzerland in 2009 (http://www.bag.admin.ch), underlining the representativeness of the spot sample.
A significantly higher number of patients were male (267; 57.2%), as found in other studies (11, 12, 21) . The reason for this dimorphism in campylobacteriosis is yet unknown, but it has been speculated that there are sexual differences concerning handling and consumption of meat (21) . However, Strachan et al. (25) challenged this view by showing similar differences in rates of campylobacteriosis even in children younger than 1 year old, in whom behaviors are expected to be similar regardless of gender. Moreover, these authors observed similarly different predispositions toward campylobacteriosis based on gender when male and female mice were infected with C. jejuni.
In terms of age (Table 1) , patients in the travel group were significantly younger (median, 30 years) than those of the domestic group (median, 38 years) (P ϭ 0.021).
The distribution of species (91.0% C. jejuni and 9.0% C. coli) reflected the proportion found in other studies from various countries and confirms C. jejuni as the main causative agent of campylobacteriosis (11, 23) . There was no association between Campylobacter species and age, gender, or travel history. This contrasts with an English study which described a dependence between C. coli and female and older patients (11) .
Multilocus sequence typing (MLST), flaB typing, and genetic determination of resistance to quinolones and macrolides, the two main groups of antibiotics used for treatment of severe cases, based on the sequencing of gyrA and 23S rRNA gene fragments, respectively, were performed as described previously (2, 5, 6, 17, 19) . In contrast to the previously described protocol (17) , 5ϫ FIREPol master mix ready to load (Solis BioDyne, Tartu, Estonia) was used. This led to the following composition for each 30.0-l multiplex PCR: 0.4 M appropriate primer, 1ϫ FIREPol master mix ready to load, 1.0 l lysate (approximately 30 ng DNA), and the addition of MgCl 2 up to a final concentration of 5 mM. Data analysis was performed as previously described by Kittl et al. (16) .
MLST resulted in 111 sequence types (STs), and flaB typing resulted in 87 types; 17 of each were new ( Table 2 ). The C. jejuni isolates showed much higher diversity than the C. coli isolates, as indicated by the distribution of the strains within different clonal complexes (CCs). Of the investigated C. coli strains, 95.0% could be assigned to CC828, confirming a higher clonality within this species (17, 24, 26) .
Despite the many CCs within the C. jejuni strains, the majority of strains (62.0%) could be assigned to the three most common CCs, i.e., CC21, CC48, and CC257. These lineages were frequently found in human samples described in other studies from different countries (6, 18, 23) . This suggests that they might be the best adapted or most pathogenic for humans. Interestingly, as previously described (16), less than 2.0% of C. jejuni isolates belonged to CC45, which is the most common CC found in humans in most countries and especially in Finland (15, 23) . As poultry is supposed to be the main source of campylobacteriosis, the number of human isolates belonging to CC45 is remarkably low even though it was one of the most frequent CCs found in Swiss broilers (28) . There is no obvious explanation for this, and further investigation is needed.
As with previous investigations, flaB typing was poorly congruent with MLST (17, 28) . Thus, a combination of MLST and flaB typing increased discrimination, as reflected in a higher Simpson's index of diversity: 0.970 compared to 0.928 for MLST and 0.921 for flaB typing alone. This provided appropriate information for the study of Campylobacter epidemiology.
Only 25 out of 65 combined MLST-flaB genotypes, found in the group of travel-associated cases and represented by 51.2% of isolates, matched those of the isolates obtained from domestic cases. The existing overlap of these two groups was due mainly to ST-21, ST-50, and ST-48 combined with flaB type 103, which were represented in both of them and which are the most frequent STs worldwide (15, 16, 18) . Conversely, the new STs found among 2.6% of domestic strains, together with ST-3963, which was first described in isolates from Swiss broilers in 2008 and which also appeared among the domestic isolates, might represent clones that are endemic to Switzerland. The difference in population structures of the two groups of isolates was confirmed by a low proportional similarity index (PSI, 0.35) (10) .
A significantly higher number of quinolone-resistant strains was found among travel-associated cases (56.0%) than among domestic cases (39.4%) ( Table 2) . Foreign travel as a risk factor for infection with quinolone-resistant Campylobacter species strains had been described previously, but the reason for this remains unknown (14) . The rates of quinolone-resistant strains in humans in different countries range from 0% to over 80%, and this variation could be ascribed to the divergent use of quinolones in foodproducing animals (8) . A correlation between licensing quinolone use in food animals and the appearance of resistant strains in humans has been shown previously (1) .
There was no significant difference in the rates of quinolone resistance between strains of domestic origin and those from patients who have traveled to member countries of the European Union. This could be due to similar regulations in Switzerland and European Union member countries, because both ban the use of antibiotics as feed additives (8) . In contrast, a considerably higher rate of quinolone resistance was observed in strains acquired in Asia, consistent with previous reports (7, 14) . In addition, travelers to Asia and Latin America often take preventive antibiotics, such as quinolones (7).
A high number of resistant strains in the group of travelassociated cases belonged to STs which did not occur in the group of domestic cases. Strains with the common STs found in both groups showed no significant difference in antibiotic resistance.
Most strains resistant to quinolones (88.4%) possessed the C257T transition in the gyrA gene (Table 3) ; this is the most frequent mutation in C. jejuni and C. coli (2) . Interestingly, we found a strong association between the double mutation C257T C310A and the domestic isolates representing ST-50 and flaB type 103, data in support of a clone endemic to Switzerland. At position 310, a substitution of serine (TCA) for proline (CCA), conferring resistance to quinolones, is normally observed (2). The effect on resistance of the transversion from CCA (proline) to ACA (threonine) found in our strains could not be tested because of the presence of the C257T mutation, which singly confers quinolone resistance.
The only isolate resistant to macrolides was also phenotypically resistant to quinolones. Remarkably, it possessed a novel double mutation within the gyrA triplet coding for Thr86 that led to Thr86Val (GenBank accession no. JN815082). This strain was isolated from a patient who had traveled to Bali, and it had probably undergone different selection pressures than the other isolates.
The analysis of quinolone resistance with respect to gender revealed a significantly higher percentage in women (48.7%) than in men (38.4%) (P ϭ 0.029), a finding, to our knowledge, not described before. There might be a connection with urinary tract infections, which are more frequently diagnosed in women than in men and, in many cases, treated with quinolones (13) . This might lead to the secondary acquisition of posttherapeutic resistance to this class of antibiotics in Campylobacter. In contrast to another study which described higher rates of quinolone resistance in C. coli (27) , we found no significant difference in antibiotic resistance rates between C. jejuni and C. coli.
In conclusion, there are differences between Swiss domestic and travel-associated Campylobacter isolates with respect to genotype and quinolone resistance. 17 (6) 5 (2) 18 (5) 5 (4) 45 (17) 20-29 39 (24) 11 (9) 48 (16) 10 (5) 108 (54) 30-39
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